Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionprostaglandin-endoperoxide synthase activity

PTGS1 PTGS2

1.50e-062252GO:0004666
GeneOntologyMolecularFunctionperoxidase activity

PXDN PTGS1 PTGS2

7.19e-0565253GO:0004601
GeneOntologyMolecularFunctionoxidoreductase activity, acting on peroxide as acceptor

PXDN PTGS1 PTGS2

7.88e-0567253GO:0016684
GeneOntologyMolecularFunctionolfactory receptor activity

OR52A5 OR52A1 OR52N2 OR52E8 OR52N4

1.70e-04431255GO:0004984
GeneOntologyMolecularFunctionantioxidant activity

PXDN PTGS1 PTGS2

2.36e-0497253GO:0016209
GeneOntologyMolecularFunctionoxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen

PTGS1 PTGS2

4.44e-0425252GO:0016702
GeneOntologyMolecularFunctionoxidoreductase activity, acting on single donors with incorporation of molecular oxygen

PTGS1 PTGS2

4.80e-0426252GO:0016701
GeneOntologyMolecularFunctionG protein-coupled receptor activity

OR52A5 OR52A1 CNR2 OR52N2 OR52E8 OR52N4

6.35e-04884256GO:0004930
GeneOntologyMolecularFunctionheme binding

PXDN PTGS1 PTGS2

9.13e-04154253GO:0020037
GeneOntologyMolecularFunctiontransmembrane signaling receptor activity

OR52A5 IL17RD OR52A1 CNR2 OR52N2 OR52E8 OR52N4

1.05e-031353257GO:0004888
GeneOntologyMolecularFunctiontetrapyrrole binding

PXDN PTGS1 PTGS2

1.10e-03164253GO:0046906
GeneOntologyMolecularFunctiondioxygenase activity

PTGS1 PTGS2

6.65e-0398252GO:0051213
GeneOntologyBiologicalProcesscyclooxygenase pathway

PTGS1 PTGS2

7.71e-0511252GO:0019371
GeneOntologyBiologicalProcessregulation of muscle contraction

ANK2 SETD3 PTGS1 PTGS2

9.61e-05202254GO:0006937
GeneOntologyBiologicalProcessregulation of smooth muscle contraction

SETD3 PTGS1 PTGS2

1.17e-0479253GO:0006940
GeneOntologyBiologicalProcessdetection of chemical stimulus involved in sensory perception of smell

OR52A5 OR52A1 OR52N2 OR52E8 OR52N4

1.48e-04432255GO:0050911
GeneOntologyBiologicalProcesssensory perception of smell

OR52A5 OR52A1 OR52N2 OR52E8 OR52N4

2.09e-04465255GO:0007608
GeneOntologyBiologicalProcesscellular oxidant detoxification

PXDN PTGS1 PTGS2

2.35e-04100253GO:0098869
GeneOntologyBiologicalProcessdetection of chemical stimulus involved in sensory perception

OR52A5 OR52A1 OR52N2 OR52E8 OR52N4

2.53e-04485255GO:0050907
GeneOntologyBiologicalProcessdetection of chemical stimulus

OR52A5 OR52A1 OR52N2 OR52E8 OR52N4

3.62e-04524255GO:0009593
GeneOntologyBiologicalProcesssensory perception of chemical stimulus

OR52A5 OR52A1 OR52N2 OR52E8 OR52N4

4.41e-04547255GO:0007606
GeneOntologyBiologicalProcesscellular detoxification

PXDN PTGS1 PTGS2

4.75e-04127253GO:1990748
GeneOntologyBiologicalProcessregulation of muscle system process

ANK2 SETD3 PTGS1 PTGS2

5.37e-04317254GO:0090257
GeneOntologyBiologicalProcesssmooth muscle contraction

SETD3 PTGS1 PTGS2

5.43e-04133253GO:0006939
GeneOntologyBiologicalProcessregulation of brown fat cell differentiation

FLCN PTGS2

5.61e-0429252GO:0090335
GeneOntologyBiologicalProcessdetection of stimulus involved in sensory perception

OR52A5 OR52A1 OR52N2 OR52E8 OR52N4

5.85e-04582255GO:0050906
GeneOntologyBiologicalProcesscellular response to toxic substance

PXDN PTGS1 PTGS2

6.18e-04139253GO:0097237
GeneOntologyBiologicalProcessprostaglandin biosynthetic process

PTGS1 PTGS2

8.66e-0436252GO:0001516
GeneOntologyBiologicalProcesspositive regulation of smooth muscle contraction

PTGS1 PTGS2

8.66e-0436252GO:0045987
GeneOntologyBiologicalProcessprostanoid biosynthetic process

PTGS1 PTGS2

8.66e-0436252GO:0046457
GeneOntologyBiologicalProcessdetoxification

PXDN PTGS1 PTGS2

1.11e-03170253GO:0098754
GeneOntologyBiologicalProcessmaintenance of blood-brain barrier

PTGS1 PTGS2

1.18e-0342252GO:0035633
GeneOntologyBiologicalProcessmuscle contraction

ANK2 SETD3 PTGS1 PTGS2

1.28e-03400254GO:0006936
MousePhenodecreased urine prostaglandin level

PTGS1 PTGS2

3.68e-063162MP:0011564
MousePhenoabnormal urine prostaglandin level

PTGS1 PTGS2

1.23e-055162MP:0011562
MousePhenodisorganized secondary lens fibers

PXDN ANK2

8.05e-0512162MP:0002579
MousePhenoincreased prostaglandin level

PTGS1 PTGS2

9.51e-0513162MP:0009814
MousePhenodecreased prostaglandin level

PTGS1 PTGS2

9.51e-0513162MP:0009815
MousePhenoallodynia

PTGS1 PTGS2

1.28e-0415162MP:0003177
MousePhenoabnormal stomach pH

PTGS1 PTGS2

2.08e-0419162MP:0008004
MousePhenoabnormal response of heart to induced stress

ANK2 PTGS1 PTGS2

2.40e-04109163MP:0004484
MousePhenoabnormal renal glomerular filtration rate

PTGS1 PTGS2

3.63e-0425162MP:0002847
MousePhenoabnormal prostaglandin level

PTGS1 PTGS2

3.93e-0426162MP:0009811
MousePhenoincreased susceptibility to weight gain

ANK2 PTGS2 CSPG4

4.12e-04131163MP:0005455
MousePhenoincreased susceptibility to age related obesity

ANK2 CSPG4

4.24e-0427162MP:0003212
MousePhenoabnormal renal glomerular filtration

PTGS1 PTGS2

4.90e-0429162MP:0013284
MousePhenodecreased susceptibility to induced thrombosis

PTGS1 PTGS2

5.24e-0430162MP:0031120
MousePhenoabnormal keratinocyte differentiation

PTGS1 PTGS2

5.24e-0430162MP:0002656
MousePhenoincreased epididymal fat pad weight

ANK2 CSPG4

5.97e-0432162MP:0009288
MousePhenoabnormal parturition

SETD3 PTGS1

6.35e-0433162MP:0002907
MousePhenoabnormal uterine environment

PTGS1 PTGS2

7.15e-0435162MP:0004014
MousePhenodecreased susceptibility to autoimmune disorder

NLRP10 PTGS1 PTGS2

1.04e-03180163MP:0005351
MousePhenoabnormal nociception after inflammation

PTGS1 PTGS2

1.13e-0344162MP:0002736
MousePhenoenlarged cecum

PTGS1 CNR2

1.29e-0347162MP:0009476
MousePhenoabnormal lens fiber morphology

PXDN ANK2

1.40e-0349162MP:0002840
DomainPEROXIDASE_3

PXDN PTGS1 PTGS2

2.53e-0710253PS50292
DomainHaem_peroxidase

PXDN PTGS1 PTGS2

2.53e-0710253IPR010255
Domain-

PXDN PTGS1 PTGS2

2.53e-07102531.10.640.10
DomainHaem_peroxidase_animal

PXDN PTGS1 PTGS2

2.53e-0710253IPR019791
DomainAn_peroxidase

PXDN PTGS1 PTGS2

2.53e-0710253PF03098
DomainELM2

RCOR3 RCOR1

1.33e-0413252PF01448
DomainELM2

RCOR3 RCOR1

1.33e-0413252PS51156
DomainELM2_dom

RCOR3 RCOR1

1.33e-0413252IPR000949
DomainELM2

RCOR3 RCOR1

1.33e-0413252SM01189
DomainOlfact_rcpt

OR52A5 OR52A1 OR52N2 OR52E8 OR52N4

1.51e-04393255IPR000725
DomainGPCR_Rhodpsn_7TM

OR52A5 OR52A1 CNR2 OR52N2 OR52E8 OR52N4

2.06e-04670256IPR017452
Domain7tm_1

OR52A5 OR52A1 CNR2 OR52N2 OR52E8 OR52N4

2.18e-04677256PF00001
DomainG_PROTEIN_RECEP_F1_1

OR52A5 OR52A1 CNR2 OR52N2 OR52E8 OR52N4

2.32e-04685256PS00237
DomainG_PROTEIN_RECEP_F1_2

OR52A5 OR52A1 CNR2 OR52N2 OR52E8 OR52N4

2.43e-04691256PS50262
DomainGPCR_Rhodpsn

OR52A5 OR52A1 CNR2 OR52N2 OR52E8 OR52N4

2.45e-04692256IPR000276
DomainSANT_dom

RCOR3 RCOR1

5.48e-0426252IPR017884
DomainSANT

RCOR3 RCOR1

6.36e-0428252PS51293
DomainMyb_DNA-binding

RCOR3 RCOR1

9.96e-0435252PF00249
DomainMYB_LIKE

RCOR3 RCOR1

1.17e-0338252PS50090
DomainSANT

RCOR3 RCOR1

2.03e-0350252SM00717
DomainSANT/Myb

RCOR3 RCOR1

2.19e-0352252IPR001005
Domain-

NLRP10 ANK2

6.83e-03932521.10.533.10
DomainDEATH-like_dom

NLRP10 ANK2

7.71e-0399252IPR011029
Domain7TM_GPCR_Srsx

OR52A5 CNR2

9.77e-03112252SM01381
DomainEGF

PTGS1 PTGS2

1.22e-02126252PF00008
PathwayBIOCARTA_ACETAMINOPHEN_PATHWAY

PTGS1 PTGS2

1.54e-055182M22024
PathwayBIOCARTA_ACETAMINOPHEN_PATHWAY

PTGS1 PTGS2

4.29e-058182MM1547
PathwayWP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS

PTGS1 PTGS2

5.51e-059182M48307
PathwayKEGG_OLFACTORY_TRANSDUCTION

OR52A5 OR52A1 OR52N2 OR52E8 OR52N4

9.93e-05389185M14091
PathwayREACTOME_OLFACTORY_SIGNALING_PATHWAY

OR52A5 OR52A1 OR52N2 OR52E8 OR52N4

1.38e-04417185M4072
PathwayREACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX

PTGS1 PTGS2

1.60e-0415182MM14870
PathwayREACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX

PTGS1 PTGS2

1.60e-0415182M27149
PathwayWP_OVERVIEW_OF_NANOPARTICLE_EFFECTS

PTGS1 PTGS2

2.60e-0419182M39473
PathwayWP_ASPIRIN_AND_MIRNAS

PTGS1 PTGS2

2.60e-0419182M48319
PathwayBIOCARTA_EICOSANOID_PATHWAY

PTGS1 PTGS2

2.89e-0420182MM1529
PathwayWP_EICOSANOID_SYNTHESIS

PTGS1 PTGS2

3.50e-0422182MM15961
PathwayBIOCARTA_EICOSANOID_PATHWAY

PTGS1 PTGS2

3.50e-0422182M22003
PathwayWP_EICOSANOID_SYNTHESIS

PTGS1 PTGS2

3.83e-0423182M39382
PathwayWP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122

PTGS1 PTGS2

7.01e-0431182M42531
PathwayWP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX

PTGS1 PTGS2

7.01e-0431182M39851
PathwayWP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION

PTGS1 PTGS2

7.47e-0432182MM15850
PathwayWP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX

PTGS1 PTGS2

7.94e-0433182MM15918
PathwayWP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321

PTGS1 PTGS2

8.43e-0434182M48061
PathwayREACTOME_SENSORY_PERCEPTION

OR52A5 OR52A1 OR52N2 OR52E8 OR52N4

9.65e-04636185M41834
PathwayWP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION

PTGS1 PTGS2

1.48e-0345182M39355
PathwayWP_OMEGA6FATTY_ACIDS_IN_SENESCENCE

PTGS1 PTGS2

2.36e-0357182M48332
PathwayKEGG_ARACHIDONIC_ACID_METABOLISM

PTGS1 PTGS2

2.44e-0358182M5410
PathwayREACTOME_ARACHIDONIC_ACID_METABOLISM

PTGS1 PTGS2

2.52e-0359182M27140
PathwayREACTOME_ARACHIDONIC_ACID_METABOLISM

PTGS1 PTGS2

2.70e-0361182MM14861
PathwayWP_SELENIUM_MICRONUTRIENT_NETWORK

PTGS1 PTGS2

5.28e-0386182M39385
PathwayWP_OXIDATIVE_STRESS_AND_REDOX_PATHWAY

PTGS1 PTGS2

6.02e-0392182MM15823
Pubmed

Endogenous cyclo-oxygenase activity regulates mouse gastric surface pH.

PTGS1 PTGS2

4.96e-07225212411530
Pubmed

Localization of prostaglandin-H synthase-1 and -2 in mouse skin: implications for cutaneous function.

PTGS1 PTGS2

4.96e-0722529665805
Pubmed

Expression of the two isoforms of prostaglandin endoperoxide synthase (PGHS-1 and PGHS-2) during adipose cell differentiation.

PTGS1 PTGS2

4.96e-0722529256365
Pubmed

Cyclooxygenase-2 is expressed in bladder during fetal development and stimulated by outlet obstruction.

PTGS1 PTGS2

4.96e-0722529362331
Pubmed

Structural determination and promoter analysis of the chicken mitogen-inducible prostaglandin G/H synthase gene and genetic mapping of the murine homolog.

PTGS1 PTGS2

4.96e-0722528424659
Pubmed

Immunohistochemical and ultrastructural localization of prostaglandin H synthase in the preimplantation mouse embryo.

PTGS1 PTGS2

4.96e-0722528882280
Pubmed

Role of COX-1 and COX-2 on skin PGs biosynthesis by mechanical scratching in mice.

PTGS1 PTGS2

4.96e-07225216815697
Pubmed

An immunohistochemical survey of nine cases of medullary carcinoma of thyroid including reactivity for Cox-1 and Cox-2 enzymes.

PTGS1 PTGS2

4.96e-07225212665651
Pubmed

An imbalance of COX level is not related to placental abruption.

PTGS1 PTGS2

4.96e-07225221561892
Pubmed

A novel anti-atherogenic role for COX-2--potential mechanism for the cardiovascular side effects of COX-2 inhibitors.

PTGS1 PTGS2

4.96e-07225217643885
Pubmed

Differential expression of cyclooxygenases in hypertrophic scar and keloid tissues.

PTGS1 PTGS2

4.96e-07225219769727
Pubmed

Peroxide-induced radical formation at TYR385 and TYR504 in human PGHS-1.

PTGS1 PTGS2

4.96e-07225219433337
Pubmed

Directed transport of neutrophil-derived extracellular vesicles enables platelet-mediated innate immune response.

PTGS1 PTGS2

4.96e-07225227845343
Pubmed

Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair.

PTGS1 PTGS2

4.96e-07225212045254
Pubmed

Ocular prostaglandin production and morphology in mice lacking a single isoform of cyclooxygenase.

PTGS1 PTGS2

4.96e-07225219767186
Pubmed

Cyclooxygenase knockout mice: models for elucidating isoform-specific functions.

PTGS1 PTGS2

4.96e-07225210487525
Pubmed

Multiple female reproductive failures in cyclooxygenase 2-deficient mice.

PTGS1 PTGS2

4.96e-0722529346237
Pubmed

Analysis of renal immunoexpression of cyclooxygenase-1 and cyclooxygenase-2 in lupus and nonlupus membranous glomerulopathy.

PTGS1 PTGS2

4.96e-07225218459455
Pubmed

Placental tissue cyclo-oxygenase 1 and 2 in pre-eclamptic and normal pregnancy.

PTGS1 PTGS2

4.96e-07225216930602
Pubmed

Cyclooxygenase and cytokine regulation in lung fibroblasts activated with viral versus bacterial pathogen associated molecular patterns.

PTGS1 PTGS2

4.96e-07225223742950
Pubmed

Prostaglandin-endoperoxide synthase genes COX1 and COX2 - novel modifiers of disease severity in cystic fibrosis patients.

PTGS1 PTGS2

4.96e-07225220720307
Pubmed

The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy.

PTGS1 PTGS2

4.96e-07225219887674
Pubmed

Cyclooxygenase in normal human tissues--is COX-1 really a constitutive isoform, and COX-2 an inducible isoform?

PTGS1 PTGS2

4.96e-07225218657230
Pubmed

Panax quinquefolium saponin combined with dual antiplatelet drugs inhibits platelet adhesion to injured HUVECs via PI3K/AKT and COX pathways.

PTGS1 PTGS2

4.96e-07225227401285
Pubmed

Cyclo-oxygenase 2 function is essential for bone fracture healing.

PTGS1 PTGS2

4.96e-07225212054171
Pubmed

Cyclooxygenase-1, but not -2, is upregulated in NB4 leukemic cells and human primary promyelocytic blasts during differentiation.

PTGS1 PTGS2

4.96e-07225215190260
Pubmed

Anti-inflammatory effect of two isoforms of COX in H. pylori-induced gastritis in mice: possible involvement of PGE2.

PTGS1 PTGS2

4.96e-07225212958020
Pubmed

Genetic polymorphisms in the cyclooxygenase-1 and cyclooxygenase-2 genes and risk of colorectal adenoma.

PTGS1 PTGS2

4.96e-07225219205707
Pubmed

Genetic Variants in Cyclooxygenase-2 Contribute to Post-treatment Pain among Endodontic Patients.

PTGS1 PTGS2

4.96e-07225226081267
Pubmed

Glutathione promotes prostaglandin H synthase (cyclooxygenase)-dependent formation of malondialdehyde and 15(S)-8-iso-prostaglandin F2α.

PTGS1 PTGS2

4.96e-07225222982857
Pubmed

Targeted cyclooxygenase gene (ptgs) exchange reveals discriminant isoform functionality.

PTGS1 PTGS2

4.96e-07225217110378
Pubmed

Distinct expression of cyclooxygenase-1 and -2 in the human thymus.

PTGS1 PTGS2

4.96e-07225211981837
Pubmed

Critical role of COX-1 in prostacyclin production by human endothelial cells under modification of hydroperoxide tone.

PTGS1 PTGS2

4.96e-07225218838483
Pubmed

Prostaglandin endoperoxide synthase-1 and -2 couple to different transmembrane stimuli to generate prostaglandin D2 in mouse bone marrow-derived mast cells.

PTGS1 PTGS2

4.96e-0722528071353
Pubmed

Differential compensation of two cyclooxygenases in renal homeostasis is independent of prostaglandin-synthetic capacity under basal conditions.

PTGS1 PTGS2

4.96e-07225229676940
Pubmed

Coordinated regulation of fetal and maternal prostaglandins directs successful birth and postnatal adaptation in the mouse.

PTGS1 PTGS2

4.96e-07225210944235
Pubmed

Variation in cyclooxygenase expression levels within the colorectum.

PTGS1 PTGS2

4.96e-07225212720297
Pubmed

Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2.

PTGS1 PTGS2

4.96e-0722528181472
Pubmed

Expanding the febrigenic role of cyclooxygenase-2 to the previously overlooked responses.

PTGS1 PTGS2

4.96e-07225216081878
Pubmed

Human cyclooxygenase-2 cDNA.

PTGS1 PTGS2

4.96e-0722521380156
Pubmed

Airway inflammation and responsiveness in prostaglandin H synthase-deficient mice exposed to bacterial lipopolysaccharide.

PTGS1 PTGS2

4.96e-07225211694451
Pubmed

Cyclooxygenase-1 and cyclooxygenase-2 in the mouse ductus arteriosus: individual activity and functional coupling with nitric oxide synthase.

PTGS1 PTGS2

4.96e-07225212922938
Pubmed

Distinct roles for cyclooxygenases 1 and 2 in interleukin-1-induced behavioral changes.

PTGS1 PTGS2

4.96e-07225212183660
Pubmed

Comparative analysis of pharmacologic and/or genetic disruption of cyclooxygenase-1 and cyclooxygenase-2 function in female reproduction in mice.

PTGS1 PTGS2

4.96e-07225211416042
Pubmed

The febrile response to lipopolysaccharide is blocked in cyclooxygenase-2(-/-), but not in cyclooxygenase-1(-/-) mice.

PTGS1 PTGS2

4.96e-07225210216176
Pubmed

Coupling between cyclooxygenases and terminal prostanoid synthases.

PTGS1 PTGS2

4.96e-07225216140261
Pubmed

Effects of Cyclooxygenase on the Urothelium of the Urinary Bladder of Mice Exposed to Pelvic Radiation.

PTGS1 PTGS2

4.96e-07225227386631
Pubmed

Susceptibility of cyclooxygenase-2-deficient mice to pulmonary fibrogenesis.

PTGS1 PTGS2

4.96e-07225212163371
Pubmed

Acetaminophen-induced hypothermia in mice is mediated by a prostaglandin endoperoxide synthase 1 gene-derived protein.

PTGS1 PTGS2

4.96e-07225215263079
Pubmed

Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts.

PTGS1 PTGS2

4.96e-07225210449516
Pubmed

Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II.

PTGS1 PTGS2

4.96e-07225212093889
Pubmed

Genetic model of selective COX2 inhibition reveals novel heterodimer signaling.

PTGS1 PTGS2

4.96e-07225216732282
Pubmed

COX-2 inhibition attenuates anorexia during systemic inflammation without impairing cytokine production.

PTGS1 PTGS2

4.96e-07225211832369
Pubmed

Altered monocyte cyclooxygenase response to lipopolysaccharide in type 1 diabetes.

PTGS1 PTGS2

4.96e-07225217130490
Pubmed

Cell-Specific Gene Deletion Reveals the Antithrombotic Function of COX1 and Explains the Vascular COX1/Prostacyclin Paradox.

PTGS1 PTGS2

4.96e-07225231510878
Pubmed

Expression of cyclooxygenase isoforms in developing rat placenta, human term placenta, and BeWo human trophoblast model.

PTGS1 PTGS2

4.96e-07225216323955
Pubmed

Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation.

PTGS1 PTGS2

4.96e-0722527510883
Pubmed

Cyclooxygenase polymorphisms and risk of cardiovascular events: the Atherosclerosis Risk in Communities (ARIC) study.

PTGS1 PTGS2

4.96e-07225217495879
Pubmed

Disruption of cyclooxygenase genes in mice.

PTGS1 PTGS2

4.96e-0722528994299
Pubmed

Interaction between COX-1 and COX-2 increases susceptibility to ischemic stroke in a Chinese population.

PTGS1 PTGS2

4.96e-07225231735164
Pubmed

Prostaglandin endoperoxide synthase gene structure: identification of the transcriptional start site and 5'-flanking regulatory sequences.

PTGS1 PTGS2

4.96e-0722521536575
Pubmed

Cyclooxygenase-1 and -2 enzymes differentially regulate the brain upstream NF-kappa B pathway and downstream enzymes involved in prostaglandin biosynthesis.

PTGS1 PTGS2

4.96e-07225216787416
Pubmed

Both constitutive and inducible prostaglandin H synthase affect dermal wound healing in mice.

PTGS1 PTGS2

4.96e-07225212118094
Pubmed

Stage- and region-specific cyclooxygenase expression and effects of a selective COX-1 inhibitor in the mouse amygdala kindling model.

PTGS1 PTGS2

4.96e-07225219523994
Pubmed

Differential COX-2 induction by viral and bacterial PAMPs: Consequences for cytokine and interferon responses and implications for anti-viral COX-2 directed therapies.

PTGS1 PTGS2

4.96e-07225223850620
Pubmed

Cyclooxygenase-1-selective inhibition prolongs gestation in mice without adverse effects on the ductus arteriosus.

PTGS1 PTGS2

4.96e-07225212189249
Pubmed

Developmental expression of the cyclo-oxygenase-1 and cyclo-oxygenase-2 genes in the peri-implantation mouse uterus and their differential regulation by the blastocyst and ovarian steroids.

PTGS1 PTGS2

4.96e-0722529156514
Pubmed

Catalytically inactive cyclooxygenase 2 and absence of prostaglandin E2 biosynthesis in murine peritoneal macrophages following in vivo phagocytosis of heat-killed Mycobacterium bovis bacillus Calmette-Guérin.

PTGS1 PTGS2

4.96e-07225217982098
Pubmed

Flipping the cyclooxygenase (Ptgs) genes reveals isoform-specific compensatory functions.

PTGS1 PTGS2

4.96e-07225229180445
Pubmed

Cyclooxygenase regulates angiogenesis induced by colon cancer cells.

PTGS1 PTGS2

4.96e-0722529630216
Pubmed

Host cyclooxygenase-2 modulates carcinoma growth.

PTGS1 PTGS2

4.96e-07225210841517
Pubmed

Cyclooxygenase enzyme expression and E series prostaglandin receptor signalling are enhanced in heavy menstruation.

PTGS1 PTGS2

4.96e-07225217264103
Pubmed

Differential gene expression patterns in cyclooxygenase-1 and cyclooxygenase-2 deficient mouse brain.

PTGS1 PTGS2

4.96e-07225217266762
Pubmed

Cyclooxygenase polymorphisms in gastric and colorectal carcinogenesis: are conclusive results available?

PTGS1 PTGS2

4.96e-07225219060633
Pubmed

The COX-2 pathway is essential during early stages of skeletal muscle regeneration.

PTGS1 PTGS2

4.96e-07225215084473
Pubmed

Cyclooxygenase-2 mediates the febrile response of mice to interleukin-1beta.

PTGS1 PTGS2

4.96e-07225211489266
Pubmed

Structural modeling and simulation studies of human cyclooxygenase (COX) isozymes with selected terpenes: implications in drug designing and development.

PTGS1 PTGS2

4.96e-07225223668350
Pubmed

Immunohistochemical localization of prostaglandin H synthase in the embryo and uterus of the mouse from ovulation through implantation.

PTGS1 PTGS2

4.96e-0722522109618
Pubmed

Platelet responsiveness to in vitro aspirin is independent of COX-1 and COX-2 protein levels and polymorphisms.

PTGS1 PTGS2

4.96e-07225217631383
Pubmed

Zymosan-induced glycerylprostaglandin and prostaglandin synthesis in resident peritoneal macrophages: roles of cyclo-oxygenase-1 and -2.

PTGS1 PTGS2

4.96e-07225216787386
Pubmed

Mucosal expression of cyclooxygenase isoforms 1 and 2 is increased with worsening damage to the gastric mucosa.

PTGS1 PTGS2

4.96e-07225215720413
Pubmed

Suppression of adipogenesis program in cultured preadipocytes transfected stably with cyclooxygenase isoforms.

PTGS1 PTGS2

4.96e-07225219416639
Pubmed

Classification using hierarchical clustering of tumor-infiltrating immune cells identifies poor prognostic ovarian cancers with high levels of COX expression.

PTGS1 PTGS2

4.96e-07225218997734
Pubmed

The Effect of Cadmium on COX-1 and COX-2 Gene, Protein Expression, and Enzymatic Activity in THP-1 Macrophages.

PTGS1 PTGS2

4.96e-07225225645360
Pubmed

COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice.

PTGS1 PTGS2

4.96e-07225212055598
Pubmed

Cyclooxygenase isozymes in oral squamous cell carcinoma:a real-time RT-PCR study with clinic pathological correlations.

PTGS1 PTGS2

4.96e-07225217624243
Pubmed

Effects of cyclooxygenase-1 and -2 gene disruption on Helicobacter pylori-induced gastric inflammation.

PTGS1 PTGS2

4.96e-07225216518767
Pubmed

Cyclooxygenase-2-dependent oxidative stress mediates palmitate-induced impairment of endothelium-dependent relaxations in mouse arteries.

PTGS1 PTGS2

4.96e-07225225149102
Pubmed

Modulation of the expression and activity of cyclooxygenases in normal and accelerated erythropoiesis.

PTGS1 PTGS2

4.96e-07225215504548
Pubmed

Regulation of the two prostaglandin G/H synthases by parathyroid hormone, interleukin-1, cortisol, and prostaglandin E2 in cultured neonatal mouse calvariae.

PTGS1 PTGS2

4.96e-0722528070358
Pubmed

Imbalanced synthesis of cyclooxygenase-derived thromboxane A2 and prostacyclin compromises vasomotor function of the thoracic aorta in Marfan syndrome.

PTGS1 PTGS2

4.96e-07225217641673
Pubmed

Genetically mediated interindividual variation in analgesic responses to cyclooxygenase inhibitory drugs.

PTGS1 PTGS2

4.96e-07225216678543
Pubmed

Role of cyclooxygenases COX-1 and COX-2 in modulating adipogenesis in 3T3-L1 cells.

PTGS1 PTGS2

4.96e-07225212576525
Pubmed

Role of Asn-382 and Thr-383 in activation and inactivation of human prostaglandin H synthase cyclooxygenase catalysis.

PTGS1 PTGS2

4.96e-07225214625295
Pubmed

Celecoxib potentiates the anticancer effect of cisplatin on vulvar cancer cells independently of cyclooxygenase.

PTGS1 PTGS2

4.96e-07225219723114
Pubmed

Platelet response to aspirin in Chinese stroke patients is independent of genetic polymorphisms of COX-1 C50T and COX-2 G765C.

PTGS1 PTGS2

4.96e-07225222972377
Pubmed

Deletion of prostaglandin E2 synthesizing enzymes in brain endothelial cells attenuates inflammatory fever.

PTGS1 PTGS2

4.96e-07225225164664
Pubmed

Compensatory prostaglandin E2 biosynthesis in cyclooxygenase 1 or 2 null cells.

PTGS1 PTGS2

4.96e-0722529463402
Pubmed

An olfactory receptor gene is located in the extended human beta-globin gene cluster and is expressed in erythroid cells.

OR52A5 OR52A1

4.96e-07225210512676
Pubmed

Expression of cyclooxygenase-1 and cyclooxygenase-2 in normal and pathological human oral mucosa.

PTGS1 PTGS2

4.96e-07225221478098
InteractionPTGIS interactions

PTGS1 PTGS2

2.16e-057212int:PTGIS
Cytoband11p15.4

NLRP10 OR52A5 OR52N2 OR52E8 OR52N4

7.39e-0820025511p15.4
CytobandEnsembl 112 genes in cytogenetic band chr11p15

NLRP10 OR52A5 OR52A1 OR52N2 OR52E8 OR52N4

4.86e-07564256chr11p15
CytobandEnsembl 112 genes in cytogenetic band chr1p35

TMEM39B CSMD2

2.54e-03137252chr1p35
GeneFamilyOlfactory receptors, family 52

OR52A5 OR52A1 OR52N2 OR52E8 OR52N4

7.16e-1049175165
GeneFamilyGATA zinc finger domain containing|Myb/SANT domain containing

RCOR3 RCOR1

1.11e-0353172532
CoexpressionGSE10240_IL22_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN

CIAO3 PTGS1 TMEM50B CNR2

3.10e-05200244M310
CoexpressionNABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA_TUMOR_CELL_DERIVED

PXDN CSPG4

5.27e-0512242M47983
ComputationalNeighborhood of MMP1

PXDN PTGS1

6.56e-0432132GNF2_MMP1
ComputationalNeighborhood of PTX3

PXDN PTGS1

8.31e-0436132GNF2_PTX3
ComputationalNeighborhood of BAG5

SETD3 TMEM50B

9.26e-0438132GCM_BAG5
ComputationalGenes in the cancer module 70.

PTGS1 CSPG4

1.19e-0343132MODULE_70
Drugpravadoline

PTGS1 PTGS2 CNR2

9.78e-089253CID000056463
DrugTolmetin

PTGS1 PTGS2

1.16e-062252DB00500
DrugPiroxicam

PTGS1 PTGS2

1.16e-062252DB00554
DrugIbuprofen

PTGS1 PTGS2

1.16e-062252DB01050
DrugLornoxicam

PTGS1 PTGS2

1.16e-062252DB06725
DrugN-(3-phenoxy-4-pyridinyl)trifluoromethanesulfonamide

PTGS1 PTGS2

1.16e-062252ctd:C468797
DrugFenoprofen

PTGS1 PTGS2

1.16e-062252DB00573
DrugKetoprofen

PTGS1 PTGS2

1.16e-062252DB01009
DrugTenoxicam

PTGS1 PTGS2

1.16e-062252DB00469
DrugKetorolac

PTGS1 PTGS2

1.16e-062252DB00465
DrugNabumetone

PTGS1 PTGS2

1.16e-062252DB00461
DrugAC1O5RN5

PTGS1 PTGS2

1.16e-062252CID006439421
DrugTiaprofenic acid

PTGS1 PTGS2

1.16e-062252DB01600
DrugAcetaminophen

PTGS1 PTGS2

1.16e-062252DB00316
DrugSC 299

PTGS1 PTGS2

1.16e-062252ctd:C409370
Drugflosulide

PTGS1 PTGS2

1.16e-062252ctd:C059178
Drug2-methoxybenzoic acid

PTGS1 PTGS2

1.16e-062252ctd:C081914
DrugOxaprozin

PTGS1 PTGS2

1.16e-062252DB00991
DrugAntrafenine

PTGS1 PTGS2

1.16e-062252DB01419
DrugTrisalicylate-choline

PTGS1 PTGS2

1.16e-062252DB01401
DrugBromfenac

PTGS1 PTGS2

1.16e-062252DB00963
DrugAntipyrine

PTGS1 PTGS2

1.16e-062252DB01435
Druggamma-Homolinolenic acid

PTGS1 PTGS2

1.16e-062252DB00154
DrugSuprofen

PTGS1 PTGS2

1.16e-062252DB00870
DrugDiflunisal

PTGS1 PTGS2

1.16e-062252DB00861
Drugcimicoxib

PTGS1 PTGS2

1.16e-062252CID000213053
DrugCarprofen

PTGS1 PTGS2

1.16e-062252DB00821
DrugMeloxicam

PTGS1 PTGS2

1.16e-062252DB00814
DrugSalsalate

PTGS1 PTGS2

1.16e-062252DB01399
DrugSalicylate-sodium

PTGS1 PTGS2

1.16e-062252DB01398
DrugMagnesium salicylate

PTGS1 PTGS2

1.16e-062252DB01397
DrugNaproxen

PTGS1 PTGS2

1.16e-062252DB00788
DrugMefenamic acid

PTGS1 PTGS2

1.16e-062252DB00784
DrugMaleimides

PTGS1 PTGS2

1.16e-062252ctd:D008301
DrugFlurbiprofen

PTGS1 PTGS2

1.16e-062252DB00712
DrugBismuth Subsalicylate

PTGS1 PTGS2

1.16e-062252DB01294
DrugLumiracoxib

PTGS1 PTGS2

1.16e-062252DB01283
DrugMDL 035

PTGS1 PTGS2

1.16e-062252CID000053454
Drugtricin

PTGS1 PTGS2

1.16e-062252ctd:C017769
DrugNepafenac

PTGS1 PTGS2

1.16e-062252DB06802
DrugPyrazoles

PTGS1 PTGS2 CNR2

1.32e-0620253ctd:D011720
Drug5,8,11-eicosatrienoic acid

PTGS1 PTGS2 CNR2

1.78e-0622253CID000004028
Drug17-hydroxy-ent-kaur-15-en-19-oic acid

PTGS1 PTGS2

3.47e-063252CID000169654
Drugfirocoxib

PTGS1 PTGS2

3.47e-063252CID000208910
Drugitazigrel

PTGS1 PTGS2

3.47e-063252CID000051087
DrugMeclofenamic acid

PTGS1 PTGS2

3.47e-063252DB00939
DrugAcetylsalicylic acid

PTGS1 PTGS2

3.47e-063252DB00945
DrugSalicyclic acid

PTGS1 PTGS2

3.47e-063252DB00936
Drugmalabaricone C

PTGS1 PTGS2

3.47e-063252ctd:C071787
Drugmalabaricone B

PTGS1 PTGS2

3.47e-063252ctd:C071788
DrugPhenylbutazone

PTGS1 PTGS2

3.47e-063252DB00812
DrugAHR-10037

PTGS1 PTGS2

3.47e-063252CID000132843
DrugEtodolac

PTGS1 PTGS2

3.47e-063252DB00749
Drugnesodine

PTGS1 PTGS2

3.47e-063252CID006475455
Drug2-propionyloxybenzoic acid

PTGS1 PTGS2

3.47e-063252CID000095938
Drug1a, 1b-dihomo-PGF2

PTGS1 PTGS2

3.47e-063252CID006443812
Drug5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulfonyl)phenyl-2(5H)-furanone

PTGS1 PTGS2

6.94e-064252ctd:C106876
DrugBalsalazide

PTGS1 PTGS2

6.94e-064252DB01014
Drug2-(6-carboxyhexyl)cyclopentanone hexylhydrazone

PTGS1 PTGS2

6.94e-064252CID000134996
Druganolignan B

PTGS1 PTGS2

6.94e-064252CID000072388
DrugFlufenamic Acid

PTGS1 PTGS2

6.94e-064252DB02266
Drugoleanolic aldehyde

PTGS1 PTGS2

6.94e-064252CID005320280
DrugAI-122

PTGS1 PTGS2

6.94e-064252CID000134058
Drug12-HPETE

PTGS1 PTGS2

6.94e-064252ctd:C021201
DrugNSC-327431

PTGS1 PTGS2

6.94e-064252CID000362637
Drugtriacontanol

PTGS1 PTGS2

6.94e-064252CID000068972
Drugprostaglandin G2

PTGS1 PTGS2

6.94e-064252ctd:C038291
Drug2-chloropyridine

PTGS1 PTGS2

6.94e-064252CID000007977
Drugprantschimgin

PTGS1 PTGS2

6.94e-064252CID000025785
DrugResveratrol

PTGS1 PTGS2

6.94e-064252DB02709
DrugNiflumic Acid

PTGS1 PTGS2

6.94e-064252DB04552
DrugC9H7BrO4

PTGS1 PTGS2

6.94e-064252CID000073922
Drugsulfanilide

PTGS1 PTGS2

6.94e-064252CID000068517
Drug8beta-prostane

PTGS1 PTGS2

6.94e-064252CID000107873
DrugSC57666

PTGS1 PTGS2

6.94e-064252CID000443373
Drugglyceryl 2-arachidonate

PTGS1 PTGS2 CNR2

7.48e-0635253ctd:C094503
DrugREV 5901

PTGS1 PTGS2 CNR2

1.04e-0539253CID000005059
Drug1-octanoyl-2-acetylglycerol

PTGS1 PTGS2

1.16e-055252CID000130710
Drugsakuranin

PTGS1 PTGS2

1.16e-055252CID000073607
Drug4'-piperidinoacetophenone

PTGS1 PTGS2

1.16e-055252CID000082561
Drugnictindole

PTGS1 PTGS2

1.16e-055252CID000065796
DrugIndomethacin

PTGS1 PTGS2

1.16e-055252DB00328
Drug4-(nitroxy)butanoic acid 4-acetylaminophenyl ester

PTGS1 PTGS2

1.16e-055252ctd:C478738
Drugfenflumizole

PTGS1 PTGS2

1.16e-055252CID000068917
DrugFlupenthixol

PTGS1 PTGS2

1.16e-055252ctd:D005475
Drug4-methylesculetin

PTGS1 PTGS2

1.16e-055252CID005319502
Drugloxoprofen

PTGS1 PTGS2

1.16e-055252ctd:C040656
DrugM 5011

PTGS1 PTGS2

1.16e-055252CID000127523
Drugdithymoquinone

PTGS1 PTGS2

1.16e-055252CID000398941
DrugDuP 697

PTGS1 PTGS2

1.16e-055252ctd:C064874
DrugPGF-M

PTGS1 PTGS2

1.16e-055252CID003082337
DrugSulindac

PTGS1 PTGS2

1.16e-055252DB00605
Drug12-HPETE

PTGS1 PTGS2 CNR2

1.40e-0543253CID000001415
Drugpalmitoylethanolamide

PTGS1 PTGS2 CNR2

1.50e-0544253CID000004671
Drug15-hydroperoxy-PGE2

PTGS1 PTGS2

1.73e-056252CID006444110
Drugdesproglumideproglumetacin

PTGS1 PTGS2

1.73e-056252CID000126678
Drugproglumetacin

PTGS1 PTGS2

1.73e-056252CID000004921
Drug2,6-dimethoxyquinol

PTGS1 PTGS2

1.73e-056252CID000096038
DrugKBT-3022

PTGS1 PTGS2

1.73e-056252CID000065870
Drugisolicoflavonol

PTGS1 PTGS2

1.73e-056252CID005318585
DiseaseAlzheimer's disease (implicated_via_orthology)

RCOR3 RCOR1 ANK2 PTGS1 PTGS2

7.36e-1057235DOID:10652 (implicated_via_orthology)
Diseasegliosarcoma (biomarker_via_orthology)

PTGS1 PTGS2

5.81e-072232DOID:3071 (biomarker_via_orthology)
Diseaseglioblastoma (biomarker_via_orthology)

PTGS1 PTGS2

3.48e-064232DOID:3068 (biomarker_via_orthology)
DiseaseIntestinal Polyps

PTGS1 PTGS2

5.80e-065232C0021846
Diseaseulcerative colitis (implicated_via_orthology)

PTGS1 PTGS2

1.22e-057232DOID:8577 (implicated_via_orthology)
DiseaseCreutzfeldt-Jakob disease (is_marker_for)

PTGS1 PTGS2

2.61e-0510232DOID:11949 (is_marker_for)
DiseaseAsthma, Occupational

PTGS1 PTGS2

2.61e-0510232C0264423
DiseaseMechanical Allodynia

PTGS1 PTGS2 CNR2

3.78e-0584233C2936719
DiseaseHyperalgesia

PTGS1 PTGS2 CNR2

3.78e-0584233C0020429
DiseaseAllodynia

PTGS1 PTGS2 CNR2

3.78e-0584233C0458247
DiseaseHyperalgesia, Secondary

PTGS1 PTGS2 CNR2

3.78e-0584233C0751212
DiseaseHyperalgesia, Primary

PTGS1 PTGS2 CNR2

3.78e-0584233C0751211
DiseaseHyperalgesia, Thermal

PTGS1 PTGS2 CNR2

3.78e-0584233C0751214
DiseaseTactile Allodynia

PTGS1 PTGS2 CNR2

3.78e-0584233C0751213
Diseaserenal cell carcinoma (biomarker_via_orthology)

PTGS1 PTGS2

5.26e-0514232DOID:4450 (biomarker_via_orthology)
DiseaseGastric ulcer

PTGS1 PTGS2

8.82e-0518232C0038358
Diseasebipolar disorder (is_marker_for)

PTGS1 PTGS2

9.86e-0519232DOID:3312 (is_marker_for)
DiseaseMarijuana Abuse

PTGS2 CNR2

2.49e-0430232C0024809
DiseaseHuntington's disease (implicated_via_orthology)

PTGS2 CNR2

2.84e-0432232DOID:12858 (implicated_via_orthology)
DiseaseKidney Neoplasm

FLCN PTGS2

4.45e-0440232C0022665
DiseaseDepression, Neurotic

PTGS2 CNR2

4.68e-0441232C0282126
DiseaseMelancholia

PTGS2 CNR2

4.68e-0441232C0025193
DiseaseDepressive Syndrome

PTGS2 CNR2

4.91e-0442232C0086133
DiseaseSchizophrenia

CSMD2 PTGS1 PTGS2 CNR2 CFAP65

5.10e-04883235C0036341
Diseaseglioblastoma (is_marker_for)

PTGS1 PTGS2

5.39e-0444232DOID:3068 (is_marker_for)
DiseaseMalignant neoplasm of kidney

FLCN PTGS2

5.64e-0445232C0740457
DiseaseEndogenous depression

PTGS2 CNR2

5.89e-0446232C0011573
DiseaseKidney Failure, Chronic

PTGS1 PTGS2

6.41e-0448232C0022661
Diseaseresponse to TNF antagonist

NLRP10 CSMD2

8.11e-0454232EFO_0004653
DiseaseAcute Cerebrovascular Accidents

ANK2 PTGS2

8.11e-0454232C0751956
DiseaseAtherogenesis

PTGS2 CNR2

9.68e-0459232C1563937
DiseasePancreatitis

PTGS2 CNR2

9.68e-0459232C0030305
DiseaseAtherosclerosis

PTGS2 CNR2

9.68e-0459232C0004153
DiseaseMental Depression

CSMD2 PTGS2 CNR2

9.83e-04254233C0011570
DiseaseCerebrovascular accident

ANK2 PTGS2

1.07e-0362232C0038454
DiseaseDepressive disorder

CSMD2 PTGS2 CNR2

1.42e-03289233C0011581

Protein segments in the cluster

PeptideGeneStartEntry
SFFNVSDGSHIFTFH

BTNL9

461

Q6UXG8
TSHGKGVFFTFHTFH

CSMD2

956

Q7Z408
VFAFTNFSSSHDHFR

CSPG4

2011

Q6UVK1
VFACSFVNFHVFHGV

CNR2

86

P34972
VLFEQAFSFHGKTFH

RCOR1

201

Q9UKL0
LFEQAFSFHGKSFHR

RCOR3

96

Q9P2K3
GQHHIFSFFAFKENR

ANK2

1396

Q01484
PAFFSFFSHRFGEHI

OR52N4

256

Q8NGI2
VSFDHAPHNFGFRFF

IL17RD

216

Q8NFM7
IFFGDEQHGFVFSHT

FLCN

141

Q8NFG4
FYSFRHISFQDFFHA

NLRP10

461

Q86W26
FLANFFSEFPCHFLH

CFAP65

1626

Q6ZU64
LLAFFSFFTHRFGSH

OR52A1

256

Q9UKL2
LLAFFSFFTHRFGSH

OR52A5

256

Q9H2C5
FFAQHFTHQFFKTDH

PTGS2

186

P35354
AAFFTFFTHRFVGHN

OR52N2

256

Q8NGI0
MFAFFAQHFTHQFFK

PTGS1

196

P23219
FFTPAFFSFLTHRFG

OR52E8

256

Q6IFG1
FVIHSGFFFDNNSHD

SETD3

321

Q86TU7
IGVHFVFDTAFSRHF

CIAO3

146

Q9H6Q4
IFNAFATAAFRFGHT

PXDN

1061

Q92626
HAFHTCGVFSTLAFF

TMEM50B

56

P56557
FFQHRIHWFSIFNSF

TM9SF3

216

Q9HD45
QFHFAFLFLTHFNTH

TMEM187

236

Q14656
AIPSDVSHFRFHFFF

TMEM39B

401

Q9GZU3